<?xml version="1.0" encoding="UTF-8"?><own:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:own="http://www.sec.gov/edgar/ownership">
  <!-- Generated by Workiva -->
  <own:headerData>
    <own:submissionType>144</own:submissionType>
    <own:filerInfo>
      <own:filer>
        <own:filerCredentials>
          <own:cik>0002124755</own:cik>
          <own:ccc>XXXXXXXX</own:ccc>
        </own:filerCredentials>
      </own:filer>
      <own:liveTestFlag>LIVE</own:liveTestFlag>



    </own:filerInfo>
  </own:headerData>
  <own:formData>
    <own:issuerInfo>
      <own:issuerCik>0001714899</own:issuerCik>
      <own:issuerName>Denali Therapeutics Inc.</own:issuerName>
      <own:secFileNumber>001-38311</own:secFileNumber>
      <own:issuerAddress>
        <com:street1>161 Oyster Point Blvd</com:street1>
        <com:city>South San Francisco</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94080</com:zipCode>
      </own:issuerAddress>
      <own:issuerContactPhone>6508668547</own:issuerContactPhone>
      <own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Chin Peter Scott</own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <own:relationshipsToIssuer>
        <own:relationshipToIssuer>Officer</own:relationshipToIssuer>
      </own:relationshipsToIssuer>
    </own:issuerInfo>
    <own:securitiesInformation>
      <own:securitiesClassTitle>Common</own:securitiesClassTitle>
      <own:brokerOrMarketmakerDetails>
        <own:name>Morgan Stanley Smith Barney LLC Executive Financial Services</own:name>
        <own:address>
          <com:street1>1 New York Plaza</com:street1>
          <com:street2>38th Fl.</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10004</com:zipCode>
        </own:address>
      </own:brokerOrMarketmakerDetails>
      <own:noOfUnitsSold>1654</own:noOfUnitsSold>
      <own:aggregateMarketValue>36867.14</own:aggregateMarketValue>
      <own:noOfUnitsOutstanding>160144391</own:noOfUnitsOutstanding>
      <own:approxSaleDate>09/04/2026</own:approxSaleDate>
      <own:securitiesExchangeName>NASDAQ</own:securitiesExchangeName>
    </own:securitiesInformation>
    <own:securitiesToBeSold>
      <own:securitiesClassTitle>Common</own:securitiesClassTitle>
      <own:acquiredDate>09/03/2026</own:acquiredDate>
      <own:natureOfAcquisitionTransaction>Restricted Stock Lapse - See Remarks</own:natureOfAcquisitionTransaction>
      <own:nameOfPersonfromWhomAcquired>Denali Therapeutics Inc.</own:nameOfPersonfromWhomAcquired>
      <own:isGiftTransaction>N</own:isGiftTransaction>
      <own:amountOfSecuritiesAcquired>1654</own:amountOfSecuritiesAcquired>
      <own:paymentDate>09/03/2026</own:paymentDate>
      <own:natureOfPayment>Equity Compensation</own:natureOfPayment>
    </own:securitiesToBeSold>
    <own:nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</own:nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <own:remarks>Shares sold to cover tax obligation from settlement of vested Restricted Stock Units.</own:remarks>
    <own:noticeSignature>
      <own:noticeDate>09/04/2026</own:noticeDate>
      <own:signature>/s/Tyler Nielsen, by power of attorney</own:signature>
    </own:noticeSignature>
  </own:formData>
</own:edgarSubmission>
